UNQUOTE

Index invests €10m in Mind-NRG

  • Susannah Birkwood
  • LinkedIn  
  • Google plus  

Index Ventures has committed €10m to Mind-NRG, a Swiss-based company that develops disease-modifying compounds for disorders affecting the central nervous system.

An initial €1.5m has been injected to enable the firm to conduct experiments into its products' effectiveness at treating illnesses such as Parkinson's, Alzheimer's and schizophrenia.

Index partner Michèle Ollier led the deal on behalf of the venture capital firm.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Susannah Birkwood on +44 20 7004 7524 or susannah.birkwood@incisivemedia.com

 

  • LinkedIn  
  • Google plus  

More on DACH

Latest News